APOE, MAPT, SNCA, and Cognitive Performance in Parkinson Disease

IMPORTANCE: Cognitive impairment (CI) is a common and disabling problem in Parkinson’s disease (PD) that is not well understood and is difficult to treat. Identification of genetic variants that influence the rate of cognitive decline or pattern of early cognitive deficits in PD might provide a clea...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:JAMA Neurol
Autors principals: Mata, Ignacio F., Leverenz, James B., Weintraub, Daniel, Trojanowski, John Q., Hurtig, Howard I., Van Deerlin, Vivianna M., Ritz, Beate, Rausch, Rebecca, Rhodes, Shannon L, Factor, Stewart A., Wood-Siverio, Cathy, Quinn, Joseph F., Chung, Kathryn A., Peterson, Amie L., Espay, Alberto J., Revilla, Fredy J., Devoto, Johnna, Hu, Shu-Ching, Cholerton, Brenna A., Wan, Jia Y., Montine, Thomas J., Edwards, Karen L., Zabetian, Cyrus P.
Format: Artigo
Idioma:Inglês
Publicat: 2014
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4227942/
https://ncbi.nlm.nih.gov/pubmed/25178429
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaneurol.2014.1455
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars